MENU
+Compare
ANTX
Stock ticker: NASDAQ
AS OF
Jun 2, 01:39 PM (EDT)
Price
$1.06
Change
-$0.00 (-0.00%)
Capitalization
31.99M

ANTX AN2 Therapeutics Forecast, Technical & Fundamental Analysis

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more

ANTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ANTX with price predictions
May 30, 2025

ANTX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ANTX moved above the 200-day moving average on May 08, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 35 cases where ANTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANTX advanced for three days, in of 175 cases, the price rose further within the following month. The odds of a continued upward trend are .

ANTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANTX as a result. In of 53 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ANTX turned negative on May 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 18 similar instances when the indicator turned negative. In of the 18 cases the stock turned lower in the days that followed. This puts the odds of success at .

ANTX moved below its 50-day moving average on April 25, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ANTX entered a downward trend on May 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.436) is normal, around the industry mean (16.282). P/E Ratio (0.000) is within average values for comparable stocks, (59.459). ANTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (270.467).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ANTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ANTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANTX is expected to report earnings to fall 17.14% to -28 cents per share on August 07

AN2 Therapeutics ANTX Stock Earnings Reports
Q2'25
Est.
$-0.29
Q1'25
Missed
by $0.10
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.13
The last earnings report on May 13 showed earnings per share of -34 cents, missing the estimate of -25 cents. With 171.22K shares outstanding, the current market capitalization sits at 31.99M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Managed Health Care
Address
1800 El Camino Real
Phone
+1 650 331-9090
Employees
41
Web
https://www.an2therapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KVUE23.870.29
+1.23%
Kenvue
MEG19.53-0.23
-1.16%
Montrose Environmental Group
ALGM25.35-0.40
-1.55%
Allegro MicroSystems
SPIR10.38-0.28
-2.63%
Spire Global
BTCM1.84-0.17
-8.46%
BIT Mining Limited

ANTX and Stocks

Correlation & Price change

A.I.dvisor tells us that ANTX and NKTX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANTX and NKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANTX
1D Price
Change %
ANTX100%
-12.40%
NKTX - ANTX
26%
Poorly correlated
-3.87%
CSLLY - ANTX
26%
Poorly correlated
-0.01%
RANI - ANTX
25%
Poorly correlated
-3.45%
CERO - ANTX
24%
Poorly correlated
-13.85%
IRON - ANTX
23%
Poorly correlated
-0.41%
More